Sensitivity issues or the presence of analytes with unidentifiable structure are typical problems during many E&L studies. Case studies and possible solutions are discussed:

  • Reasons for presence of unknown compounds and insufficient sensitivity
  • Optimization of the study design to reduce the risks
  • How to use E&L data even if sensitivity is not sufficient
  • Approaches for direct and indirect identification
  • Leachable or matrix artefacts: Approaches to assess the origin of unknown compounds

Our expert is Dr Tino Otte, Head of Sales and Consulting, Intertek Reinach, who delivered this presentation during the 2nd Annual Extractables & Leachables for Pharma Summit 2022

Please complete the form to watch our presentation.